Screener
Phathom Pharmaceuticals, Inc. PHAT Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
FAQ
- What is Phathom Pharmaceuticals, Inc.'s gross margin?
- Phathom Pharmaceuticals, Inc. (PHAT) reported gross margin of 82.9% in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s gross margin changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s gross margin decreased by 4.6% year-over-year, from 86.9% to 82.9%.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s gross margin?
- Over 2 years (2023 to 2025), Phathom Pharmaceuticals, Inc.'s gross margin has grown at a 7.4% compound annual growth rate (CAGR), from 75.5% to 87.1%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Phathom Pharmaceuticals, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude